Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

  • There is currently no data for IDOX

Replacement: Director/PDMR Shareholding

22 Apr 2026 13:00

RNS Number : 5259B
IDOX PLC
22 April 2026
 

The following amendment has been made to the 'Director/PDMR Shareholding' announcement released on 22 April 2026 at 11:24 under RNS No 5164B. Removal of square brackets "[23]". All other details remain unchanged. The full amended text is shown below.

22 April 2026

Idox plc 

("Idox", "the Company" or "the Group")

Director/PDMR Shareholding and Total Voting Rights

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and geospatial data solutions to the public and asset intensive sectors, announces that, on 22 April 2026, it has allotted and issued new ordinary shares of 1 pence each ("Ordinary Shares") pursuant to the exercise of options by four of its PDMRs, as detailed in the table below. The exercise of the options occurred immediately following the recommended cash offer by Frankel UK Bidco Limited, a company indirectly owned by Long Path Partners, to acquire the entire issued and to be issued share capital of Idox and which announced on 28 October 2025 (the "Offer") becoming unconditional.

The Company also announces that, on the same day, the PDMRs noted in the table below each unconditionally agreed to sell the Ordinary Shares (including, where relevant, the Ordinary Shares acquired on exercise of the options) at a price of 71.5p pence per share under the terms of the Offer. The transfer of the Ordinary Shares to Frankel UK Bidco Limited will take place shortly after the date on which the Offer become unconditional pursuant to the terms of the Offer.

PDMR

Role

Number of Ordinary Shares acquired following exercise of options

Exercise price per Ordinary Share

Number of Ordinary Shares sold (comprising both Ordinary Shares acquired following exercise of options and other Ordinary Shares held by the PDMR)

David Meaden

CEO

1,837,455

0p

3,290,842

Anoop Kang

CFO

1,440,477

0p

1,458,699

Jonathan Legdon

COO

1,317,258

0p

2,174,699

Christopher Stone

Chair

585,500

1p

1,521,877

Phil Kelly

NED

N/A

N/A

105,263

 

Following this notification, the PDMRs no longer hold any beneficial holding in the Company.

Admission and Total Voting Rights

Following the acceptance of proposals relating to Idox shares in connection with the Offer and following the Offer becoming unconditional an application has been made for a total of 13,160,839 new Ordinary Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will occur at 8.00 a.m. on or around 23 April 2026.

The total number of Ordinary Shares in issue following Admission will be 474,842,885. Therefore the total number of Ordinary Shares with voting rights in the Company will be 474,842,885.

The above figure of 474,842,885 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

The information below (set out in accordance with the requirements of EU Market Abuse Regulation) provides further detail in respect of the PDMRs:

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

David Meaden

2.

Reason for the notification

a.

Position/status

Chief Executive Officer

b.

Initial notification

/Amendment

 Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Idox plc

b.

LEI

213800Z3FE6PWVSUGE70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

b.

Nature of the transaction

1. Exercise of options over Ordinary Shares

2. Sale of Ordinary Shares.

c.

Price(s) and volume(s)

Price(s)

Volume(s)

1.

n/a

1,837,455

2.

71.5p

3,290,842

d.

Aggregated information

· Aggregated volume

· Price 

Price(s)

Volume(s)

1.

n/a

1,837,455

2.

71.5p

3,290,842

e.

Date of the transaction

1. 22 April 2026

2. 22 April 2026

f.

Place of the transaction

1. Outside a trading venue

2. London Stock Exchange (XLON); AIM

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Anoop Kang

2.

Reason for the notification

a.

Position/status

Chief Financial Officer

b.

Initial notification

/Amendment

 Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Idox plc

b.

LEI

213800Z3FE6PWVSUGE70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

b.

Nature of the transaction

3. Exercise of options over Ordinary Shares

4. Sale of Ordinary Shares.

c.

Price(s) and volume(s)

Price(s)

Volume(s)

3.

n/a

1,440,477

4.

71.5p

1,458,699

d.

Aggregated information

· Aggregated volume

· Price 

Price(s)

Volume(s)

3.

n/a

1,440,477

4.

71.5p

1,458,699

e.

Date of the transaction

3. 22 April 2026

4. 22 April 2026

f.

Place of the transaction

3. Outside a trading venue

4. London Stock Exchange (XLON); AIM

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Jonathan Legdon

2.

Reason for the notification

a.

Position/status

Chief Operational Officer

b.

Initial notification

/Amendment

 Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Idox plc

b.

LEI

213800Z3FE6PWVSUGE70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

b.

Nature of the transaction

5. Exercise of options over Ordinary Shares

6. Sale of Ordinary Shares.

c.

Price(s) and volume(s)

Price(s)

Volume(s)

5.

n/a

1,317,258

6.

71.5p

2,174,969

d.

Aggregated information

· Aggregated volume

· Price 

Price(s)

Volume(s)

5.

n/a

1,317,258

6.

71.5p

2,174,969

e.

Date of the transaction

5. 22 April 2026

6. 22 April 2026

f.

Place of the transaction

5. Outside a trading venue

6. London Stock Exchange (XLON); AIM

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Christopher Stone

2.

Reason for the notification

a.

Position/status

Non-executive chair and director

b.

Initial notification

/Amendment

 Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Idox plc

b.

LEI

213800Z3FE6PWVSUGE70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

b.

Nature of the transaction

1. Exercise of options over Ordinary Shares

2. Sale of Ordinary Shares.

c.

Price(s) and volume(s)

Price(s)

Volume(s)

1.

n/a

585,500

2.

71.5p

1,521,877

d.

Aggregated information

· Aggregated volume

· Price 

Price(s)

Volume(s)

1.

n/a

585,500

2.

71.5p

1,521,877

e.

Date of the transaction

1. 22 April 2026

2. 22 April 2026

f.

Place of the transaction

1. Outside a trading venue

2. London Stock Exchange (XLON); AIM

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Phil Kelly

2.

Reason for the notification

a.

Position/status

Non-executive director

b.

Initial notification

/Amendment

 Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Idox plc

b.

LEI

213800Z3FE6PWVSUGE70

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

b.

Nature of the transaction

Sale of Ordinary Shares.

c.

Price(s) and volume(s)

Price(s)

Volume(s)

71.5p

105,263

d.

Aggregated information

· Aggregated volume

· Price 

Price(s)

Volume(s)

71.5p

105,263

e.

Date of the transaction

 22 April 2026

f.

Place of the transaction

London Stock Exchange (XLON); AIM

 

For further information please contact:

 

Idox plc

+44 (0) 333 011 1200

 

Chris Stone, Non-Executive Chairman

investorrelations@idoxgroup.com 

David Meaden, Chief Executive Officer

Anoop Kang, Chief Financial Officer

 

 

Peel Hunt LLP (NOMAD and Broker)

+44 (0) 20 7418 8900

Neil Patel

 

Benjamin Cryer

 

Kate Bannatyne

 

Alice Lane

 

MHP Group

+44 (0) 7885 447944

Reg Hoare

 idox@mhpgroup.com

Matthew Taylor

Finn Taylor

 

About Idox plc

For more information see www.idoxplc.com @Idoxgroup

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKZGZDMZVGVZM
Date   Source Headline
30th Aug 20198:18 amRNSHolding(s) in Company
30th Aug 20198:16 amRNSHolding(s) in Company
30th Aug 20197:00 amRNSDirectors' Dealings & Holdings in Company
20th Aug 20199:20 amRNSHolding(s) in Company
9th Aug 20193:16 pmRNSCompletion of Acquisition of Tascomi Ltd
8th Aug 201910:56 amRNSHolding(s) in Company
6th Aug 20198:06 amRNSDirectors' Dealings & Holdings in Company
31st Jul 201910:30 amRNSFurther Details on the Fundraising
31st Jul 20197:00 amRNSProposed Fundraising via accelerated bookbuild
22nd Jul 20197:00 amRNSHalf-year Report
4th Apr 20194:17 pmRNSDirector/PDMR Share Dealing
3rd Apr 20197:00 amRNSBoard Change
29th Mar 20191:08 pmRNSResult of AGM
29th Mar 20197:00 amRNSAGM Trading Update & 2016 Prior Year Adjustment
22nd Mar 20197:00 amRNSDirectorate Change
18th Mar 20195:16 pmRNSOption Awards
12th Mar 20193:17 pmRNSDirector Dealings and Option Awards
7th Mar 20191:29 pmRNSPosting of Annual Report and Notice of AGM
21st Feb 20197:00 amRNSFinal Results for the year ended 31 October 2018
20th Feb 20192:13 pmRNSExercise of Share Options & Total Voting Rights
1st Feb 20198:20 amRNSHolding(s) in Company
29th Jan 20197:00 amRNSExtension of Banking Facilities
22nd Jan 20198:24 amRNSHolding(s) in Company
7th Jan 20192:50 pmRNSBoard Change
27th Nov 20187:00 amRNSYear End Trading Update
22nd Nov 20187:00 amRNSDirectorate Change
19th Nov 20187:00 amRNSDirectorate Change
5th Nov 20187:00 amRNSDisposal of Digital division
31st Oct 20187:00 amRNSDirectorate Change
25th Oct 20183:23 pmRNSHolding(s) in Company
19th Oct 20185:01 pmRNSHolding(s) in Company
15th Oct 20187:00 amRNSAppointment of Chief Financial Officer
12th Sep 20183:46 pmRNSHolding(s) in Company
10th Sep 201811:22 amRNSExercise of Share Options & Total Voting Rights
10th Sep 201810:02 amRNSHolding(s) in Company
5th Sep 20187:00 amRNSExercise of Share Options & Total Voting Rights
30th Aug 20187:00 amRNSDirectorate Change
17th Aug 201811:30 amRNSHolding(s) in Company
31st Jul 20189:09 amRNSHolding(s) in Company
27th Jul 20182:21 pmRNSHolding(s) in Company
25th Jul 20187:00 amRNSHalf-year Report
13th Jul 201811:33 amRNSHolding(s) in Company
10th Jul 20185:16 pmRNSNotice of half year results
4th Jul 20182:37 pmRNSHolding(s) in Company
20th Jun 20187:00 amRNSChange of Auditor
8th Jun 20184:19 pmRNSHolding(s) in Company
1st Jun 20187:00 amRNSAppointment of Chief Executive
31st May 201812:48 pmRNSHolding(s) in Company
29th May 20187:48 amRNSDirectorate Change
29th May 20187:47 amRNSHalf Year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.